Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-22T23:08:33.109Z Has data issue: false hasContentIssue false
  • English
  • Français

Lithium treatment in affective disorders: The significance of strongly elevated erythrocyte choline levels

Published online by Cambridge University Press:  18 September 2015

F. Flentge  and
C.J. Slooff
F. Flentge
Affiliation:
Dept. of Biological Psychiatry, Groningen University
C.J. Slooff
Affiliation:
Dept. of Clinical Psychiatry, Groningen University
Get access Rights & Permissions [Opens in a new window]

Extract

In manic-depressive patients treated with lithium salts the transport of choline over the erythrocyte membrane is strongly inhibited, resulting in dramatically increased erythrocyte choline levels (for review see ref. 1). Whether or not there is a relationship between this effect and treatment response is not clear. Data on this issue are scarce possibly because the measurement of treatment response in lithium prophylaxis is very difficult and time consuming. Also the effect on erythrocyte choline is specific for lithium and not for manic-depressive illness. We will address here the question of a possible relation between erythrocyte choline and clinical effects of lithium.

Keywords

lithiumcholineerythrocytesaffective disorderman ic-depressi ve illnesslithiumcholineerythrocytenaffectieve stoornissenmanische depressie
Type
Research Article
Information
Acta Neuropsychiatrica , Volume 7 , Issue 2 , June 1995 , pp. 67 - 69
Copyright
Copyright © Scandinavian College of Neuropsychopharmacology 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Literature

1.Wood, AJ, and Goodwin, GM. A review of the biochemical and neuropharmacological actions of lithium. Psychol Med 1987; 17: 579–600.CrossRefGoogle ScholarPubMed
2.Johnson, GF. Lithium and acetylcholine metabolism. In: Belmaker, RH, Sandler, M, Dahlstrom, A, eds. Progress in Catecholamine Research. Part C. New York: AR Liss, 1988: 313–20.Google Scholar
3.Bouman, TK, Niemandsverdriet-van Kampen, J, Slooff, CJ, and Ormel, J. De effectiviteit van lithiumprofylaxe bij unipolaire en bipolaire depressies en schizo-affektieve stoornissen. Tijdsch Psychiat 1985; 27: 612–24.Google Scholar
4.Damsma, G, and Flentge, F.Liquid chromatography with electrochemical detection for the determination of choline and acetylcholine in plasma and red blood cells. Failure to detect acetylcholine in blood of humans and mice. J Chromatogr biomed Appl 1988; 428: 1–8.CrossRefGoogle ScholarPubMed
5.Flentge, F, and Van den Berg, CJ. Choline administration and acetylcholine in brain. J Neurochem. 1979; 32: 1331–3.CrossRefGoogle ScholarPubMed
6.Haag, M, Haag, H, Eisenried, F, and Greil, W. RBC-choline: changes by lithium and relation to prophylactic response. Acta psychiat scand 1984; 70: 389–99.CrossRefGoogle ScholarPubMed
7.Jenden, DJ, Jope, RS, and Fraser, SL. A mechanism for the accumulation of choline in erythrocytes during treatment with lithium. Comm Psychopharmacol 1980; 4: 337–44.Google ScholarPubMed
8.Uney, JB, Marchbanks, RM, Reynolds, GP, and Perry, RH. Lithium prophylaxis inhibits choline transport in post-mortem brain. Lancet 1986; 2: 458.CrossRefGoogle ScholarPubMed
9.Janowsky, D, and Judd, L. The effect of lithium on cholinergic mechanisms. Biol Psychiat 1981; 5: 653–6.Google Scholar
10.Kuchel, PW, Hunt, GE, Johnson, GFS, Beilharz, GR, and Chapman, BE. Lithium, red blood cell choline and clinical state. A prospective study in manic-depressive patients. J affect Disord 1984; 6: 83–94.CrossRefGoogle Scholar
11.Flentge, F, and Medema, R.Lithium treatment and red cell choline: an animal model which parallels responses seen with manic depressive patients. In: Dowdall, JJ, Hawthorne, JN, eds. Cellular and Molecular Basis of cholinergic Function. Chicester: Ellis Horwood, 1987: 767–73.Google Scholar
12.Coppen, A, Abou-Saleh, MT, Milln, P, Bailey, J, and Wood, K. Decreasing lithium dosage reduces morbidity and side effects during prophylaxis. J affect Disord 1983; 5: 353–62.CrossRefGoogle ScholarPubMed
13.Jensen, HV, Olafsson, K, Andersen, J, Mellerup, E, and Plenge, P. Lithium every second day. A new treatment regimen? Lithium 1990; 1: 55–8.Google Scholar